Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Circ Cardiovasc Genet. 2010 Aug 21;3(5):462–467. doi: 10.1161/CIRCGENETICS.110.950667

Table 3.

Area under the curve (AUC) for triglycerides measured at 0, 3.5 and 6 hours after the postprandial lipemia challenge by APOE genotype group before and after 3 weeks fenofibrate treatment (160 mg/day).

ε3/ε3 ε4 Carrier ε2 Carrier
Pre-Fenofibrate N=666 N=289 N=117

AUC* 1077.7 (1022, 1136) 1210.3 (1127, 1299) §e 1340.5 (1211, 1484) §f
AUC* 1095.1 (1072, 1119) 1127.7 (1095, 1162) 1161.9 (1112, 1214)§d
Post-Fenofibrate N=454 N=203 N=81
AUC* 727.3 (689, 767) 798.3 (742, 858) §d 866.2 (778, 965)§e
AUC* 738.7 (720, 757) 754.6 (730, 779) 793.9 (756, 832) §e
*

Values are least squares means (95% CIs) with arbitrary unit adjusted for age, gender, waist circumference, and family relationship

additionally adjusted for area under the serum fenofibric acid curve

additionally adjusted for fasting (0 hour) triglyceride concentration

§

Significantly higher AUC when compared to the reference genoytype (ε3/ε3). Superscripts d, e and f signify d) P<0.05, e) P<0.005, f) P<0.0001